Back to Search
Start Over
A Case of Biopharmaceutical-Induced Catatonia and the Implication of a Novel Mechanism.
- Source :
-
The journal of ECT [J ECT] 2020 Sep; Vol. 36 (3), pp. e29-e30. - Publication Year :
- 2020
-
Abstract
- Catatonia can be described structurally as a motor dysregulation syndrome with a concomitant behavioral component. However, despite its initial recognition nearly 150 years ago, the exact pathophysiological causes underlying this syndrome are still somewhat unknown and are potentially variable. This report reviews a case of a patient with multiple catatonic episodes precipitated by the use of an immunomodulator medication, and in doing so suggests a possible mechanism speaking to the immune system's role in the etiology of some cases of catatonia.
Details
- Language :
- English
- ISSN :
- 1533-4112
- Volume :
- 36
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The journal of ECT
- Publication Type :
- Academic Journal
- Accession number :
- 32118686
- Full Text :
- https://doi.org/10.1097/YCT.0000000000000650